Stay updated with breaking news from Nasdaq Pmcb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report)’s share price was up 0.5% on Wednesday . The company traded as high as $2.22 and last traded at $2.18. Approximately 2,596 shares changed hands during trading, a decline of 84% from the average daily volume of 15,808 shares. The stock had previously closed at $2.17. PharmaCyte […]
Shares of PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report) traded up 0.5% during mid-day trading on Wednesday . The stock traded as high as $2.22 and last traded at $2.18. 2,596 shares changed hands during trading, a decline of 84% from the average session volume of 15,808 shares. The stock had previously closed at […]
PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) is one of 262 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare PharmaCyte Biotech to similar businesses based on the strength of its profitability, risk, institutional ownership, dividends, earnings, analyst recommendations and valuation. Profitability This table […]
PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) is one of 262 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare PharmaCyte Biotech to similar companies based on the strength of its analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership. Analyst […]
PharmaCyte Biotech (NASDAQ:PMCB – Get Free Report) and Cognition Therapeutics (NASDAQ:CGTX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Insider & Institutional Ownership 16.0% of PharmaCyte […]